Clinical Takeaway Topical cannabis balms were well tolerated in women with aromatase inhibitor-related joint and bone pain, addressing a common side effect that affects treatment adherence in breast cancer patients. This feasibility...
Topical Cannabis for AIMSS: Clinical Trial Evidence
Clinical Takeaway Topical cannabis balms were tolerable and feasible for women with aromatase inhibitor-related joint pain and stiffness, which affects about two-thirds of women taking these breast cancer medications. This approach could...
A Randomized, Open-Label Trial to Assess Feasibility and Tolerability of Topical Cannabis Balms for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS).
Aromatase inhibitors (AIs) are commonly used for postmenopausal women with hormone receptor-positive breast cancer. Nearly two-thirds of women on AIs have ar…